Who
Matthew D. Perry
Director
Company insider
Files Form 4 as: Director and Other, XOMA Royalty; Director, Cti Biopharma.
In numbers
- Trades disclosed
- 48
- Buys
- 1
- Sells
- 0
- Bought
- $5.0M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 11 Jan 2016
- Last trade
- 14 Jul 2026
- Last filed
- 14 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Jul 2026filed 14 Jul 2026 | XOMA RoyaltyBiotechnology | SEC FORM 4 Code J | —24,138 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,222 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,052 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —15,222 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —5,052 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —8,167 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —6,152 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —5,101 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —8,996 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative | SEC FORM 4 Code D | —10,967 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —8,167 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —6,152 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,101 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —8,996 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royaltyoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,967 at $0.00 | filing |
| 14 Jul 2026filed 14 Jul 2026 | XOMA Royalty | SEC FORM 4 Code J | —24,138 | filing |
| 21 May 2026filed 26 May 2026 | XOMA RoyaltyBiotechnology | SEC FORM 4 Code A | —3,586 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | XOMA Royalty | SEC FORM 4 Code A | —3,586 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | XOMA Royalty | SEC FORM 4 Code A | —5,971 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | Xoma | SEC FORM 4 Code A | —6,070 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.